XML 44 R33.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue Recognition - Drug Discovery (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Drug Discovery Services      
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]      
Milestone payment yet to be achieved $ 2,500 $ 1,350  
Revenue recognized with milestones 2,171 $ 1,350  
Drug discovery contribution      
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]      
Deferred revenue $ 738   $ 1,718